Navigation Links
PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
Date:3/14/2013

The forward-looking statements in this release involve a number of risks and uncertainties.  The Company's actual future results and actual events may differ significantly from those suggested or indicated in the forward-looking statements contained in this release.  Important factors that might cause such a difference include, but are not limited to, the market price of the Company's stock prevailing from time to time, the nature of other investment opportunities presented to the Company from time to time, the Company's cash flow from operations, general economic conditions and other factors discussed more fully in the section entitled "Risk Factors" of the Company's Quarterly Report on Form 10-Q for the quarter ended December 31, 2012 as filed with the SEC on February 4, 2013, which "Risk Factors" discussion is incorporated by reference in this press release.  The Company specifically disclaims any obligation to update these forward-looking statements in the future.  These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

CONTACTS:

James Winschel, Senior Vice President and Chief Financial Officer


Jill Baker, Corporate Vice President of Investor Relations


+1-781-434-4118


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PAREXEL International To Present At Raymond James Investors Conference And Barclays Capital Healthcare Conference
2. PAREXEL International To Present At Citi Global Healthcare Conference
3. PAREXEL International Reports Second Quarter Fiscal Year 2013 Results
4. PAREXEL International To Present At Oppenheimer Healthcare Conference
5. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
6. PAREXEL and Salem State University Launch Clinical Trial Management Graduate Program
7. PAREXEL International to Present at Robert Baird Healthcare Conference
8. PAREXEL Strengthens Outcomes Research Capabilities To Help Biopharma Meet Commercialization Goals
9. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
10. PAREXEL And Korea Drug Development Fund Announce Alliance To Accelerate Global Drug Development And Commercialization
11. PAREXEL Announces Date of Fourth Quarter and Fiscal Year 2012 Earnings Release and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... STAMFORD, Conn. , Aug. 31, 2015 /PRNewswire/ ... Ltd., and Purdue Pharma L.P. announced today that they ... development and commercialization of Eisai,s clinical candidate lemborexant (development ... III clinical development for the treatment of insomnia. ... and Purdue Pharma will share the costs of lemborexant ...
(Date:8/31/2015)... 2015 Bionomics Limited (ASX:BNO, ADR:BMICY), a biopharmaceutical ... therapeutics for the treatment of diseases of the central ... BNC101 IND submission has passed review by the US ... a Phase 1 clinical trial in patients with metastatic ... prior to 31 December 2015. Bionomics, CEO ...
(Date:8/31/2015)... , Aug. 31, 2015 Research ... addition of the "Prescription Pain Drugs - ... Marijuana - Global Markets, Competitors and Opportunities: 2015 ... their offering. Pain is defined ... with actual or potential tissue damage. At some ...
Breaking Medicine Technology:Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 2Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 3Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 4Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant 5Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3
... DIEGO, Jan. 7, 2011 ADVENTRX Pharmaceuticals, Inc. (NYSE ... has entered into definitive agreements to sell 8,184,556 units ... certain healthcare-focused investors, and other institutional investors for a ... to ADVENTRX of approximately $22.5 million.  Each unit consists ...
... Jan. 7, 2011 WaferGen Biosystems, Inc. (OTC Bulletin ... state-of-the-art genomic analysis systems, today announced that it will ... Annual OneMedForum Business Development and Investment Conference for emerging ... JP Morgan Healthcare Conference in San Francisco, January 11-13, ...
Cached Medicine Technology:ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 2ADVENTRX Pharmaceuticals Announces Capital Raise of $22.5 Million 3WaferGen to Present at OneMedForum San Francisco 2011 2
(Date:9/1/2015)... , ... September 01, 2015 , ... Dr. Trace Curry ... JourneyLite of Cincinnati. In the last month the FDA has approved two intra-gastric ... ™. These procedures represent the first incisionless, reversible, weight loss procedures available to ...
(Date:9/1/2015)... Sarasota, Fla. (PRWEB) , ... September 01, 2015 , ... ... to be one of the first in the area to offer RADIESSE® filler treatment ... help to reduce the prominence of tendons and veins in the hands, delivering smooth, ...
(Date:9/1/2015)... ... September 01, 2015 , ... September is Baby Safety Month, ... safety labels and stickers to keep little ones' safety top of mind at all ... has a particular focus. According to the JPMA's Baby Safety Zone website, this year's ...
(Date:8/31/2015)... Knoxville, TN (PRWEB) , ... September 01, 2015 , ... ... function and other clinically relevant measures for physical therapy patients. The Registry is being ... President of FOTO, Inc. stated "We are happy to be selected to contribute FOTO ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... ... updated to include a wealth of information for specific translation services within the ... expertise and an incredible track record of successful work. , ITC Global Translations ...
Breaking Medicine News(10 mins):Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 2Health News:SkinSmart Dermatology in Sarasota is Now Offering RADIESSE to Rejuvenate Hands 3Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 2Health News:Lightning Labels Can Help Make A Difference This Baby Safety Month 3Health News:FOTO Selected as Official Registry Partner with Physical Therapy Outcomes Registry 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 2Health News:GoMarketing Announces Major Updates to ITC Global Translations Website http://www.ITCGlobalTranslations.com 3
... and Learn for a Lifetime", MILPITAS, Calif., April ... maker of OneTouch(R) Blood Glucose Meters for,people with diabetes, ... for kids with diabetes to attend a diabetes camp ... which runs through,May 20, is available at http://www.DiabetesAndKids.com ...
... China, April 11 /Xinhua-PRNewswire-FirstCall/ -- Linkwell,Corporation (Linkwell) ... and distributor of healthcare related disinfectants in ... Shanghai LiKang,Disinfection Hi-Tech Company, Ltd., (LiKang Disinfectant) ... (MOH) and Ministry of Human Resources and,Social ...
... says Chicago father of 3 who has early-onset version ... foreman Jim Mueller was in his early 30s when his ... equipment, where he was, and where he was going. Sometimes ... nothing prepared the Mueller family for the doctor,s verdict. , ...
... to evaluate palpable breast lesions, they can rule out ... conducted by researchers at Baystate Health in Springfield, MA. ... protocol. , We were interested in finding out ... together, in excluding breast cancer in women with palpable ...
... ablation in the treatment of colorectal liver metastases is ... to a recent study conducted by researchers at Charit, ... ablation (RFA) has become a widely used treatment option ... from some primary tumors, if surgery is not an ...
... April 11 Registration is now,open for ... for,environmentally preferable practices and green building. The ... Care Without Harm,along with partners Consorta, the ... Pittsburgh Medical Center., CleanMed attracts major ...
Cached Medicine News:Health News:OneTouch(R) Laugh & Learn Sweepstakes to Award Scholarships for Summer Camp Experiences to Children with Diabetes 2Health News:OneTouch(R) Laugh & Learn Sweepstakes to Award Scholarships for Summer Camp Experiences to Children with Diabetes 3Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 2Health News:Linkwell Corporation Selected to Train and License all Disinfectant and Pest Control Professionals in China and for the Beijing Olympics 3Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 2Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 3Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 4Health News:When a Mind Begins to Disappear: A Young Family's Journey to the Dark Side 5Health News:Mammography plus sonography can help rule out breast cancer in patients with palpable lesions 2Health News:Creating Healing Environments: Healthcare Industry's Largest Sustainability Conference to be Held May 20-22 in Pittsburgh 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: